Skip to main content

Table 3 Factors associated with antenatal HAART use

From: Characteristics and management of HIV-1-infected pregnant women enrolled in a randomised trial: differences between Europe and the USA

 

N (%)

OR (95% CI)

AOR (95% CI)

p-value

Ethnicity

    

   White

309 (23)

1.0

1.0

 

   Black

793 (59)

1.06 (0.82, 1.39)

0.84 (0.62, 1.13)

0.2470

   Other

248 (18)

1.15 (0.82, 1.62)

0.96 (0.66, 1.39)

0.8374

Geographic area

    

   Europe

372 (28)

1.0

1.0

 

   USA

978 (72)

1.79 (1.39, 2.30)

1.82 (1.40, 2.38)

<0.0001

Mode of delivery

    

   Vaginal delivery or non-elective caesarean

910 (67)

1.0

1.0

 

   Elective caesarean

440 (33)

0.80 (0.64, 1.01)

0.99 (0.76, 1.28)

0.9366

CD4 count (entry)

    

   < 400 cells per ml

586 (43)

1.0

1.0

 

   ≥400 cells per ml

764 (57)

0.43 (0.35, 0.54)

0.36 (0.28, 0.46)

<0.0001

CD4 count (delivery)

    

   < 400 cells per ml

543 (40)

1.0

1.0

 

   ≥400 cells per ml

807 (60)

0.49 (0.40, 0.62)

0.76 (0.56, 1.03)

0.0757

Viral load (entry)

    

   Undetectable

570 (44)

1.00

1.0

 

   Detectable

740 (56)

0.58 (0.46, 0.72)

0.48 (0.38, 0.61)

<0.0001

Viral load (delivery)

    

   Undetectable

626 (53)

1.0

1.0

 

   Detectable

555 (47)

0.79 (0.62, 0.99)

0.97 (0.71, 1.31)

0.8197